| Jan 9 2019 |
CFIUS Filing Clearance: Speedcast International Limited and Globecomm Systems |
Squire Patton Boggs (US) LLP |
| Jan 8 2019 |
The Eliminating Kickbacks in Recovery Act: A Critical Analysis of an Altered Landscape for Financial Relationships with Clinical Laboratories |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Enforcement |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
In the Midst of a Federal Government Shutdown, Tax-Exempt Bond Community Receives Long-Awaited Final Public Notice and Approval Regulations |
Greenberg Traurig, LLP |
| Jan 8 2019 |
Reminder to Perform Annual ISO/ESPP Reporting in January 2019 |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Good Manufacturing Practice |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Clinical Investigations |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
Top Five Labor Law Developments for December 2018 |
Jackson Lewis P.C. |
| Jan 8 2019 |
FDA 2018 Year in Review: Cannabis |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
How to Report a Ponzi Scheme and Earn an SEC Whistleblower Award |
Zuckerman Law |
| Jan 8 2019 |
FDA 2018 Year in Review: Tobacco |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
Uncertainty Returns to the Employment Landscape in 2019 |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 8 2019 |
FDA 2018 Year in Review: Laboratory-Developed Tests and Precision Medicine |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Medical Devices |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Drug Supply Chain Security Act |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Digital Health |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
FDA 2018 Year in Review |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
HHS Issues Cybersecurity Practices for Health Care Industry |
Robinson & Cole LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Advertising and Promotion |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
Day 1 Notes on the 2019 JP Morgan Healthcare Conference |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 8 2019 |
Export Sanctions List: Know Your Customer |
von Briesen & Roper, s.c. |
| Jan 8 2019 |
FDA 2018 Year in Review: Food |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
Federal District Court Rules HHS Cuts to 340B Reimbursement 'Exceeded' Authority |
Dinsmore & Shohl LLP |
| Jan 8 2019 |
Weekly IRS Roundup December 31, 2018 – January 4, 2019 |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
CFPB Finalizes Off-Balanced Approach to Public Disclosure of HMDA Data |
Ballard Spahr LLP |
| Jan 8 2019 |
Supreme Court Upholds Parties’ Right To Contract In First Arbitration-Related Decision Of Term (US) |
Squire Patton Boggs (US) LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Drug Quality Security Act Implementation |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
How Manufacturers Can Work With Social Media Influencers |
ArentFox Schiff LLP |
| Jan 8 2019 |
FDA 2018 Year in Review: Drugs |
McDermott Will & Schulte LLP |
| Jan 8 2019 |
Personal Injury: The New Phenomenon of Personal Injury on E-Scooters |
PracticePanther |
| Jan 8 2019 |
Can an EPA or State Agency Information Demand Trigger a Liability Insurer’s Duty to Defend? |
Barnes & Thornburg LLP |
| Jan 8 2019 |
10 Retailers to Watch for a Bankruptcy Filing in 2019 |
Stark & Stark |
| Jan 8 2019 |
Arbitration Awards and Confidentiality Revisited |
Squire Patton Boggs (US) LLP |
| Jan 8 2019 |
EPA Denies TSCA Section 21 Petition Seeking Increased Asbestos Reporting |
Bergeson & Campbell, P.C. |
| Jan 8 2019 |
Researchers Survey Nanosafety Research in the European Union and U.S. |
Bergeson & Campbell, P.C. |
